SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-023587
Filing Date
2021-06-14
Accepted
2021-06-14 16:58:14
Documents
2
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4057
2 EX-24 DOCUMENT attachment1.htm EX-24 4158
  Complete submission text file 0000899243-21-023587.txt   9631
Mailing Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801
Business Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801 (857) 444-0553
Ayala Pharmaceuticals, Inc. (Issuer) CIK: 0001797336 (see all company filings)

IRS No.: 823578375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AYALA PHARMACEUTICALS, INC. OPPENHEIMER 4 REHOVOT L3 7670104
Business Address
Sone Todd (Reporting) CIK: 0001811299 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39279 | Film No.: 211015256